Abstract
Objective: Information on single nucleotide polymorphisms in the estrogen receptor beta (ERβ) gene is lacking for the African American population. Methods: In this study, we systematically screened the coding and flanking intron regions of the ERβ gene in 49 healthy African American individuals. Results: We detected four novel variants, of which one variant (963T→C) resulted in amino acid change from phenylalanine to leucine at position 289, referred to as ERβF289L. This receptor variant was characterized in vitro for transcriptional activity and ligand-binding. These studies revealed that ERβF289L had reduced estrogen binding affinity and impaired response to 17β-estradiol induced transactivation compared to the wild-type ERβ. Conclusion: This novel variant might confer genetic susceptibility to certain endocrine related diseases in African Americans.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 379-383 |
| Number of pages | 5 |
| Journal | Pharmacogenetics and Genomics |
| Volume | 16 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2006 |
Keywords
- Estrogen receptor beta
- Ligand
- Transactivation
- Variant
ASJC Scopus subject areas
- Genetics
- Pharmacology
Fingerprint
Dive into the research topics of 'Functional characterization of a novel variant of estrogen receptor beta identified in screening of DNA derived from African Americans'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS